Skip to main content

Balyasny Asset Management L.P.

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1218710 Chicago, IL

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$441,042
-$10,235,872 QoQ
Shares Held
3,598
-96.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#223
of 343 holders
Holding Since
Dec 2023
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Derivatives in PTGX

reported options exposure · as of Jun 30, 2024
CallValue
$0
CallShares
0
PutValue
$1,992,375
PutShares
57,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. PTGX ranks #155 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PTGX

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $441,042 3,598
2026-03-31 $10,676,914 101,299
2024-06-30 $1,992,375 57,500
2023-12-31 $1,158,033 50,503